RHOFADE Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "RHOFADE Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

RHOFADE Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on RHOFADE and covers the following critical aspects of this drug:

• United States patents
• Drug prices
• Finished product suppliers
• Raw active pharmaceutical ingredient (API) sources

Topics Covered

• Profile for RHOFADE
• US Patents
• US Regulatory Exclusivity
• International (ex US) Patents
• Drug Prices - Average Pharmacy Cost
• Drug Prices - Best Wholesale Price
• Finished Product Suppliers
• Bulk API Sources

Companies Featured

• Allergan Inc.
• Sigma-Aldrich
• Novoseek
• Mp Biomedicals
• Akos Consulting & Solutions
• Finetech Industry Limited
• Chemmol
• Abblis Chemicals.Cn
• Ak Scientific Inc. (Aksci)
• Chemtik
• Emd Millipore
• Nanjing Kaimubo
• Abachemscene
• Medchemexpress Mce
• An Pharmatech
• Tocris Bioscience
• Mcule
• Alsachim
• Boc Sciences
• Biosynth
• Glentham Life Sciences Ltd.
• Molepedia
• Ichemical Technology USA Inc
• Apexbio Technology
• Abovchem Llc
• Chemshuttle
• LGC Standards
• Clearsynth
• Ochem
• Chemieliva Pharmaceutical Co. Ltd
• Musechem
• Abcr Gmbh
• 3B Scientific (Wuhan) Corp
• Alfa Aesar
• and many more...
  

For more information about this report visit https://www.researchandmarkets.com/research/9lzhnd/rhofade_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005433/en/